Press "Enter" to skip to content

Tag: market

Season 2, Episode 15: Healthcare, Tech Stocks May Not Be As Defensive As Believed

Published May 13, 2020

With Chris Brown of Aristides Capital

Christopher Brown of Aristides Capital joins the podcast to discuss his investment strategy, which has produced positive returns every calendar year since 2008.

Update: This podcast episode has been transcribed! Read it here.

In Brown’s view, healthcare and information technology stocks should not be treated as defensive investments that will protect portfolios in times of stress — especially after their recent run-up. There are reasons many companies in this sector are overvalued and could see their shares drop as the economy begins to see further difficulties from coronavirus.

Aristides Capital has an active short book, which framed most of the second half of the conversation.  

Content Segments: 

  • Why investors’ thinking about defensive stocks may be misguided (4:49)
  • Growth stocks’ recent performance is reminiscent of the late-1990s tech bubble (7:05)
  • The concerns with healthcare stocks (11:45)
  • Background on the guest (15:07)
  • Some of the red flags short sellers look for and why the “big picture” is often more pertinent (20:22)
  • Inovio Pharmaceuticals (NASDAQ: INO) discussion (22:52)
  • CytoDyn Inc. (OTC: CYDY) discussion (25:44)
  • Vuzix Corp. (NASDAQ: VUZI) discussion (28:37)
  • Accelerate Diagnostics (NASDAQ: AXDX) discussion (30:59)
  • Insider purchases are not always a bullish indicator (35:02)
  • Tesla Inc. (NASDAQ: TSLA) discussion, at the guest’s suggestion (host didn’t want to go there originally) and why it could be an indicator for future market direction (36:17)
  • Reasons to be bearish on markets and the economy (39:17)
  • How to protect your portfolio against inflation (42:13)

Highlights From Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment

Season 2, Episode 14: The Anti-Quant Quant, Beating Indexes With Three ETFs

Published May 6, 2020

With Chad Glauser, Alpine Quantitative Management

Chad Glauser of Denver-based Alpine Quantitative Management joins the podcast to discuss his fund’s strategy of using just three ETFs as a way to manage risk, gauge volatility, and produce returns.

The three ETFs track short-term Treasuries, long-term bonds, and the S&P 500. Alpine has been actively trading the strategy since late 2017 after an incubation period of about two years. The approach has worked, with the fund beating the hedge fund index for 22 straight months (and counting).

Content:
(Spotify users can click on the timestamp to link to the segment in question)

  • About the strategy: quick background and using volatility as an indicator (1:10)
  • The “real-world example” of what happened in January and February, and how the fund adopted (2:42)
  • How often, and quickly, the portfolio adjusts and why it is 100% allocated at all times (4:39)
  • The current view of markets (5:46)
  • Why Alpine views itself as the “anti-quant” quant (9:04)
  • Background on Chad Glauser (12:35)
  • How to get in touch (20:04)

Quick Video Highlight via Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment

Season 2, Episode 13: Buy Individual Stocks or Bonds, Not ETFs

Published April 29, 2020

With Maya Joelson, Metapoint Advisors

Maya Joelson, founder and president of Metapoint Advisors, joins the podcast to discuss her view of exchange-traded funds.

These instruments are seen as efficient and cheap ways for investors, especially retail investors, to gain access to various asset classes. But this is misguided, especially when it comes to ETFs tracking bond markets. Even stock ETFs aren’t always a good idea. Investors are better served picking individual securities themselves (or hiring somebody to do it for them).

Content segments (with timestamp):

  • A short history on the rise of ETFs in the U.S. (2:10)
  • Why bond ETFs don’t make as much sense as equity ETFs (6:49)
  • How long before investors get wise to this? (10:41)
  • What about stock ETFs, how efficient are they? (15:20)
  • Background on the guest (20:24)
  • “Better Safe Than SARS-y”: Looking back on the call to derisk portfolios in early February and where we are now (25:43) 
  • Buy stocks that should do well in this environment: consumer staples, healthcare, Kraft Heinz, Chewy (29:53)

Highlights From Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment